Nov 07, 2017 13:48 pm UTC| Business
Press release - No. 10 / 2017Zealand Pharma will attend the Jefferies Healthcare Conference in London and the Bryan Garnier Co Healthcare Conference in Paris, both in November Copenhagen, November 7, 2017 -...
One Horizon Group Regains Compliance with NASDAQ Listing Requirement
Nov 07, 2017 13:46 pm UTC| Business
LONDON, Nov. 07, 2017 -- One Horizon Group, Inc. (NASDAQ:OHGI) (“Company”) today announced that it received a letter from the NASDAQ Listing Qualifications Staff (“Staff”) on November 6, 2017, notifying the Company that...
Reis, Inc. Announces Third Quarter 2017 Results
Nov 07, 2017 13:45 pm UTC| Business
Total Revenue Grows 4.8%; Subscription Revenue Rises 6.2% — Revenue Growth and Margin Expansion Drive Results — NEW YORK, Nov. 07, 2017 -- Reis, Inc. (NASDAQ:REIS) (“Reis” or the “Company”), a leading provider of...
Ultragenyx Completes Tender Offer and Acquisition of Dimension Therapeutics
Nov 07, 2017 13:43 pm UTC| Business
NOVATO, Calif., Nov. 07, 2017 -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) ("Ultragenyx" or the "Company"), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases,...
Realtree Fishing Named Exclusive Camouflage Pattern of FLW
Nov 07, 2017 13:37 pm UTC| Business
COLUMBUS, Ga., Nov. 07, 2017 -- Realtree, the worldwide leader in camouflage, recently released its new Realtree Fishing camouflage and brand, which are now teamed with Fishing League Worldwide (FLW) to further that...
Collegium Receives FDA Approval for sNDA for Xtampza® ER
Nov 07, 2017 13:31 pm UTC| Business
CANTON, Mass., Nov. 07, 2017 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announced today that the U.S. Food and Drug Administration (FDA) approved its Supplemental New Drug Application (sNDA) to enhance the label...
Fortress Biotech Announces Pricing of Series A Preferred Stock Offering
Nov 07, 2017 13:31 pm UTC| Business
NEW YORK, Nov. 07, 2017 -- Fortress Biotech, Inc. (Nasdaq:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today...